María Salud García-Gutiérrez is currently an Associate Professor at the Instituto De Neurociencias at Miguel Hernandez University, Alicante, Spain. She graduated from Universidad Miguel Hernandez in 2006 and received a Doctorate from Universidad Miguel Hernandez in 2011. She received the ECNP Fellowship Award (2013) granted by the European College of Neuropsychopharmacology Society. She was granted a Marie Curie Postdoctoral Fellowship (European Research Council) in 2012. She has been a keynote speaker at conferences and meetings of international and national scientific societies including the International Congress on Dual Pathology (2015, 2017) and the European Society for Biomedical Research on Alcoholism (ESBRA) Congress (2015). From July 2016 to June 2017, she was the vice dean of the Degree of Pharmacy (Miguel Hernandez University). Since last December 2017, she has been the vice dean of Projection of the Degree of Pharmacy (Miguel Hernandez University). Her research has focused mainly on the role of the cannabinoid type 2 receptor (CB2) receptor in neuropsychiatric (anxiety, depression, and schizophrenia) and neurodegenerative disorders (Parkinson’s disease (PD)), and addictive behaviors.